FDA brief opposes stay allowing legal sales of Myblu…

US – General: The US Food and Drug Administration (FDA) has submitted a brief to the US Court of Appeals for the Columbia Circuit in Washington DC opposing Fontem’s court-issued stay allowing their Myblu products to continue to be legally sold in the US market. The FDA argues that the “irreparable harm” that Fontem has asserted (the inability to market its products » Continue Reading. ...

Restricted content. Do you want to read more?